{"name":"Pathios Therapeutics Pty Ltd","slug":"pathios-therapeutics-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNQWlPQTZ0cFZoOXBjOGg3NmdWNUdmX0wtWVVmUlVFOVpTQUsydnhlXzk4b2VpbzZDUE95TkJkVDRDcVZWR3RkT2FDd2FuLThlMFlaN2VsZUNTVi1XVWJST2NIVGdISVVRWlNnZGstMkRWQXlIOUdrWFFvOC1BV215VFphemExWXFSTFNmMFl1TGZmeTRkSVJhSExZOXJMcktwZnZGRFFTajBpRzJVSVF2UG5kYlZ0dFdIb0VqU3dIZG1KYlJCdERiajBreWNxWFdoM1B3UV95TnUtVUpSZGJTa05FTUtxemd0NS01R2M2c2ppdTdKOVhvelVseWt3OHRxRzlydGFHa0JCa2hxdnk3WUNrN0pBYzJlbTNzLWtsZ00tWUlYYm5vMUxOYUdsUQ?oc=5","date":"2024-11-20","type":"trial","source":"PR Newswire","summary":"Pathios Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GPR65 Inhibitor PTT-4256 in Patients with Advanced Solid Cancers - PR Newswire","headline":"Pathios Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GPR65 Inhibitor PTT-4256 in Patien","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}